Search results for "Pain measurement"

showing 10 items of 358 documents

Thermal Thresholds Predict Painfulness of Diabetic Neuropathies

2004

OBJECTIVE—Pathophysiology explaining pain in diabetic neuropathy (DN) is still unknown. RESEARCH DESIGN AND METHODS—Thirty patients with peripheral DN (17 men and 13 women; mean age 52.4 ± 2.5 years) were investigated. Fifteen patients had neuropathic pain, and 15 patients were free of pain. Patients were followed over 2 years and examined at the beginning and thereafter every 6 months. Clinical severity and painfulness of the DN were assessed by the neuropathy impairment score and visual analog scales (VASs). Cold and warm perception thresholds as well as heat pain thresholds were obtained for evaluation of Aδ- and C-fibers. Nerve conduction velocities (NCVs) and vibratory thresholds were …

MalePain Thresholdmedicine.medical_specialtyHot TemperatureDiabetic neuropathyVisual analogue scaleEndocrinology Diabetes and MetabolismElectromyographyRisk AssessmentSeverity of Illness IndexDiabetic NeuropathiesPredictive Value of TestsReference ValuesDiabetes mellitusSeverity of illnessInternal MedicinemedicineHumansHeart rate variabilityThermosensingPain MeasurementProbabilityAdvanced and Specialized Nursingmedicine.diagnostic_testElectromyographybusiness.industryMiddle AgedPrognosismedicine.diseaseCold TemperatureElectrophysiologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2HyperalgesiaCase-Control StudiesSensory ThresholdsAnesthesiaPredictive value of testsNeuropathic painPhysical therapyFemalebusinessDiabetes Care
researchProduct

Learning influence on the behavioral structure of rat response to pain in hot-plate

2011

Aim of the research was to study, by means of descriptive and multivariate analyses, whether, and how, learning influences the behavioral structure of rat response to pain. To this purpose, a hot-plate test daily repetition procedure was carried out on male Wistar rats for five days. A 6-day interval without stimulation elapsed before last test was carried out on day 12. After composition of an ethogram, descriptive (number, latency, per cent distribution) and multivariate analyses (cluster, stochastic) were carried out for each scheduled test day. One-way ANOVA and Newman-Keuls post-hoc test for multiple comparisons revealed significant changes for climbing, jumping, front-paw licking and …

MalePain Thresholdmedicine.medical_specialtyHot TemperatureMultivariate analysisHot-platePainStimulationMotor ActivityAudiologymedicine.disease_causeSettore BIO/09 - FisiologiaBehavioral NeuroscienceEthogramJumpingSniffingReaction TimemedicineAnimalsLearningRats WistarBehavioral strategiesPain MeasurementProbabilityAnalysis of VarianceCommunicationbusiness.industryMultivariate analysiRatsDisease Models AnimalClimbingAnalysis of varianceLickingbusinessPsychology
researchProduct

Thermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fibre neuropathy from primary restless legs syndrome.

2010

This study aimed to assess thermal and mechanical perception and pain thresholds in primary idiopathic restless legs syndrome and secondary restless legs syndrome associated with small fibre neuropathy. Twenty-one patients (age: 53.4 + or - 8.4, n = 3, male) with primary restless legs syndrome and 13 patients (age: 63.0 + or - 8.2, n = 1, male) with secondary restless legs syndrome associated with small fibre neuropathy were compared with 20 healthy subjects (age: 58.0 + or - 7.0; n = 2, male). Differential diagnosis of secondary restless legs syndrome associated with small fibre neuropathy was based on clinical symptoms and confirmed with skin biopsies in all patients. A comprehensive quan…

MalePain Thresholdmedicine.medical_specialtyHot TemperaturePhotoperiodPainNeurological disorderVibration03 medical and health sciences0302 clinical medicinePhysical StimulationRestless Legs Syndromemental disordersThreshold of painPressureMedicineHumans030212 general & internal medicineRestless legs syndromeAgedPain MeasurementSkinmedicine.diagnostic_testbusiness.industryHyperesthesiaPeripheral Nervous System DiseasesMiddle Agedmedicine.diseasenervous system diseasesSurgerybody regionsCold TemperatureNociceptionTouch PerceptionAnesthesiaSensory ThresholdsNeuropathic painSkin biopsyHyperalgesiaFemaleNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryBrain : a journal of neurology
researchProduct

Effects of age and gender in patients receiving doses of opioids for breakthrough pain proportional to background opioid doses.

2019

Aim: To identify the role of age and gender in analgesic and adverse effects after administering fentanyl products for breakthrough pain (BT), given in doses proportional to opioid doses given for background pain. Methods: Data from nine studies, in which patients with BP were given fentanyl products in doses proportional to their basal opioid regimen, were analyzed. Results: A total 462 patients presenting 1905 episodes of BP were included in this analysis. In older patients, the decrease in pain intensity was more pronounced 15 min after administration of a BP medication. No gender differences were found. No significant differences in frequency and intensity of adverse effects for age and…

MalePain medicineAnalgesicFentanyl03 medical and health sciencesBasal (phylogenetics)Age0302 clinical medicinemedicineHumans030212 general & internal medicineCancer painAdverse effectAgedPain Measurementbusiness.industryBreakthrough PainAge FactorsGenderGender IdentityFentanylAnalgesics OpioidRegimenTreatment OutcomeOncologyOpioid030220 oncology & carcinogenesisAnesthesiaFemaleCancer painbusinessmedicine.drugSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
researchProduct

The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting.

2013

Abstract The dose of rapid onset opioids to be given for breakthrough cancer pain (BTcP) is controversial. Dose proportional to the basal opioid regimen seem to be safe and effective in hospital units. However, data in other less protected settings, like home care, are lacking. The aim of this open-label study was to assess the efficacy and safety in a group of patients with BTcP followed at home, after giving a dose of fentanyl buccal tablets (FBT) proportional to the opioid basal regimen, skipping the steps for dose titration. Consecutive patients admitted to a home care program presenting BTcP episodes and receiving stable doses of opioids for background pain were selected. Data from fou…

MalePain medicineSettore MED/41 - AnestesiologiaOpioidSettore MED/42 - Igiene Generale E ApplicataHome careFentanylDose-Response RelationshipBuccalBreakthrough-episodic painNeoplasmsmedicine80 and overHumansCancer painAdverse effectAgedPain MeasurementAged 80 and overAnalgesicsDose-Response Relationship Drugbusiness.industryBreakthrough PainAdministration BuccalBuccal administrationMiddle AgedFentanyl buccal tabletHome Care ServicesAnalgesics OpioidOpioidsFentanylRegimenTreatment OutcomeBasal (medicine)OpioidOncologyCancer pain; Breakthrough-episodic pain; Fentanyl buccal tablet; Opioids; Home careAnesthesiaAdministrationFemaleBreakthrough-episodic pain; Cancer pain; Fentanyl buccal tablet; Home care; Opioids; Administration Buccal; Aged; Aged 80 and over; Analgesics Opioid; Breakthrough Pain; Dose-Response Relationship Drug; Female; Fentanyl; Home Care Services; Humans; Male; Middle Aged; Neoplasms; Pain Measurement; Tablets; Treatment Outcome; OncologyDrugCancer painbusinessmedicine.drugTablets
researchProduct

The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.

2013

Abstract OBJECTIVE: The aim of this study was to prospectively assess the efficacy and safety of sublingual fentanyl (SLF) in doses proportional to opioid doses used for background analgesia for the treatment of BTP of cancer patients. METHODS: A sample of patients admitted to an acute palliative care unit, presenting breakthrough pain (BTP) episodes and receiving stable doses of opioids for background pain was selected to assess the efficacy and safety of SLF used in doses proportional to the basal opioid regimen used for the management of BTP. For each patient, data from four consecutive episodes were collected. For each episode, nurses collected changes in pain intensity and adverse effe…

MalePalliative careAdministration SublingualSettore MED/41 - AnestesiologiaMANAGEMENT BTPSettore MED/42 - Igiene Generale E ApplicataFentanylQuality of lifemedicineHumansAdverse effectAgedPain Measurementbreakthrough pain; FENTANYL; MANAGEMENT BTPbusiness.industryPalliative CareFENTANYLGeneral MedicineMiddle Agedbreakthrough painAnalgesics OpioidRegimenTreatment OutcomeBasal (medicine)OpioidAnesthesiaQuality of LifeFemalebusinessCancer painmedicine.drug
researchProduct

The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen.

2010

OBJECTIVES: To determine the efficacy and safety of different opioids used in doses proportional to the basal opioid regimen for the management of breakthrough pain (BP). METHODS: In 66 patients consecutive patients admitted to a pain relief and palliative care unit, the efficacy and safety of different opioids used in doses proportional to the basal opioid regimen for the management of breakthrough pain (BP) were assessed. The choice of the opioid to be administered as rescue medication was based on the characteristics of patients, clinical stability, compliance, preference, and so on. For each episode, nurses were instructed to routinely collect changes in pain intensity and emerging prob…

MalePalliative careBreakthrough PainAdministration OralPainDrug Administration ScheduleSex FactorsClinical ProtocolsMedicinebreakthrough pain; acute palliative care unit; opioidsHumansAgedPain MeasurementAnalgesicsDose-Response Relationship Drugbusiness.industryPalliative CareAge FactorsopioidsMiddle Agedacute palliative care unitbreakthrough painClinical trialAnalgesics OpioidRegimenAnesthesiology and Pain MedicineNociceptionTreatment OutcomeBasal (medicine)OpioidAnesthesiaFemaleNeurology (clinical)businessCancer painmedicine.drug
researchProduct

Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain.

2014

Abstract Abstract Objective: The aim of this study was to assess the efficacy and tolerability of tapentadol (TP) for a period of 4 weeks in patients who were already treated by opioids. Methods: A convenience sample of 30 patients was selected for a prospective observational cohort study. Cancer patients who were receiving at least 60 mg of oral morphine equivalents were selected. Patients discontinued their previous opioid analgesics before starting TP, in doses calculated according the previous opioid consumption (1:3.3 ratio with oral morphine equivalents). The subsequent doses were changed according to the patients' needs for a period of 4 weeks. Oral morphine was offered as a breakthr…

MalePalliative careReceptors Opioid muAdverse effectSettore MED/42 - Igiene Generale E ApplicataCohort StudiesNeoplasmsReceptorsDrug Dosage CalculationsProspective StudiesAdverse effects; Cancer pain; Palliative care; TapentadolCancer painPain MeasurementAnalgesicsMorphineMedicine (all)General MedicineMiddle AgedTapentadolAnalgesics OpioidTapentadolTreatment OutcomeItalyTolerabilityAnesthesiaPalliative careFemaleDrugDrug Monitoringmedicine.drugCohort studyAdverse effects; Cancer pain; Palliative care; Tapentadol; Aged; Analgesics Opioid; Cohort Studies; Dose-Response Relationship Drug; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Italy; Karnofsky Performance Status; Male; Middle Aged; Morphine; Neoplasms; Pain Management; Pain Measurement; Phenols; Prospective Studies; Receptors Opioid mu; Treatment Outcome; Pain; Medicine (all)PainOpioidDose-Response RelationshipPhenolsmedicineHumansPain ManagementKarnofsky Performance StatusAdverse effectAgedDose-Response Relationship DrugAdverse effectsbusiness.industryCancermedicine.diseaseOpioidmubusinessCancer pain
researchProduct

Pain intensity as prognostic factor in cancer pain management

2015

Aim The aim of this study was to prospectively assess the prognostic value of initial pain intensity and its duration in advanced cancer patients. Methods A prospective study was conducted in a sample of patients with cancer requiring pain control. Patients underwent standard analgesic strategies used in our palliative care units. Pain intensity was measured at admission (T0) and after successful dose titration or opioid/route switching within a week (Ts). Patients were also asked about their pain intensity reported 15 days before admission (T-15). Doses of opioids and duration of opioid use were recorded. Patients were also assessed for the presence of incident pain, neuropathic pain, alco…

MalePalliative careSettore MED/42 - Igiene Generale E ApplicataSeverity of Illness IndexPain assessmentNeoplasms80 and overProspective StudiesCancer painProspective cohort studyCancerPain MeasurementAged 80 and overPrognostic factorAnalgesicsPalliative CareAssessment tools; Cancer; Cancer pain; Opioid; Opioid analgesics; Opioid response; Pain assessment; Pain intensity; Pain measurement; Prognostic factors; Aged; Aged 80 and over; Analgesics; Analgesics Opioid; Female; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Neuralgia; Pain; Pain Management; Pain Measurement; Palliative Care; Prognosis; Prospective Studies; Stress Psychological; Treatment Outcome; Severity of Illness Index; Anesthesiology and Pain MedicineAssessment toolMiddle AgedPrognosisAnalgesics OpioidAssessment toolsTreatment OutcomeAnesthesiaNeuropathic painFemalemedicine.drugOpioid responsePain assessmentAnalgesicPainOpioidPain intensityPrognostic factorsStressOpioid analgesicAssessment tools; Cancer; Cancer pain; Opioid; Opioid analgesics; Opioid response; Pain assessment; Pain intensity; Pain measurement; Prognostic factors; Anesthesiology and Pain MedicinemedicineHumansPain ManagementAdverse effectAgedbusiness.industryAnesthesiology and Pain MedicineLogistic ModelsOpioidOpioid analgesicsPsychologicalNeuralgiaCancer painbusinessStress Psychological
researchProduct

Headache attributed to aeroplane travel: the first multicentric survey in a paediatric population affected by primary headaches

2018

BACKGROUND: This multicentric survey investigates the prevalence and characteristics of Airplane Headache in children affected by primary headaches. METHODS: Patients with symptoms of Airplane Headache were recruited from nine Italian Pediatric Headache Centres. Each patient was handed a structured questionnaire which met the ICHD-III criteria. RESULTS: Among 320 children suffering from primary headaches who had flights during their lifetime, 15 (4.7%) had Airplane Headache, with mean age of 12.4 years. Most of the patients were females (80%). The headache was predominantly bilateral (80%) and localized to the frontal area (60%); it was mainly pulsating, and lasted less than 30 min in all c…

MalePediatricsNeurologyPhotophobiaAircraftHeadache Disorderlcsh:MedicineAirplane0302 clinical medicinePhotophobiaSurveys and QuestionnairesSurveys and Questionnaire030212 general & internal medicineChildChildrenAeroplane travelPain MeasurementTravelICHD-IIIHeadacheGeneral MedicinePediatric headachePhonophobiaItalyChild PreschoolFemalemedicine.symptomResearch ArticleHumanAdultmedicine.medical_specialtyAdolescentHeadache Disorders03 medical and health sciencesPrimary headachePrimary headachePrimary headachesmedicineHumansPreschoolAeroplane travel; Airplane; Children; Headache; ICHD-III; Pediatric headache; Primary headaches; Adolescent; Adult; Child; Child Preschool; Female; Headache Disorders; Humans; Italy; Male; Pain Measurement; Photophobia; Aircraft; Surveys and Questionnaires; Travelbusiness.industrylcsh:RMean agePediatric headacheAnesthesiology and Pain MedicineConcomitantNeurology (clinical)business030217 neurology & neurosurgeryPaediatric population
researchProduct